The B7-1 Study": Belatacept Conversion in Proteinuric Renal Transplant Recipients and B7-1 Positivity Status on Biopsy: an Interventional Multi-Center Trial
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 03 Apr 2017
At a glance
- Drugs Belatacept (Primary)
- Indications Proteinuria
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 30 Mar 2017 Planned End Date changed from 1 Jul 2018 to 1 Jun 2020.
- 30 Mar 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Jan 2020.